A novel recombinant multisubunit vaccine against Chlamydia

Area of Science:

• Immunology
• Vaccinology
• Microbiology

Background:

• Chlamydia trachomatis infections require effective long-term control through vaccination.
• Developing vaccines necessitates suitable delivery vehicles for robust mucosal immune responses.
• Vibrio cholerae ghosts (VCG) are non-toxic delivery vehicles with adjuvant properties, inducing T and B cell responses.

Purpose of the Study:

• To evaluate recombinant VCG (rVCG) as a delivery vehicle for Chlamydia subunit vaccines.
• To compare the immunogenicity and efficacy of single versus multiple chlamydial subunit vaccines delivered by rVCG.
• To determine if rVCG can induce protective immunity against Chlamydia infections.

Main Methods:

• Production of rVCG expressing chlamydial outer membrane proteins via genetic engineering.
• Intramuscular immunization of mice with single or multiple subunit rVCG vaccines.
• Immunological analysis of Th1 responses and assessment of protective immunity.

Main Results:

• Both single and multiple subunit rVCG vaccines induced strong Th1 responses (mucosal and systemic).
• The multiple subunit vaccine demonstrated an advantage, inducing a higher frequency of Th1 cells.
• The multiple subunit vaccine conferred a greater level of protective immunity compared to the single subunit vaccine.

Conclusions:

• rVCG is a viable delivery vehicle for Chlamydia subunit vaccines.
• Multiple subunit vaccines delivered via rVCG enhance protective immunity against Chlamydia.
• The level of Th1 response elicited by a vaccine correlates with its ability to confer protective immunity.